Senior insider sale
Chief Business Officer at PTC THERAPEUTICS, INC. — senior position signals high conviction
$5.22M
68.59K shares
What this filing means
PAUWELS ERIC plans to sell 68.59K shares of PTC THERAPEUTICS, INC. valued at approximately $5.22M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/8/2026ACC: 0001959173-26-000221
Officer· Chief Business Officer
Since Apr 2020
68.59K
Shares to sell
$5.22M
Approx. market value
1.45K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
1/7/2026
1.45KTotal acquired1.45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/7/2026 | Restricted Stock Vesting Compensation | 1.45K | — |
| Total | 1.45K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
1.35K
Market value
$104.8K
1/7/2026
—Completed
Units to sell
1.79K
Market value
$137.7K
1/6/2026
—Completed
Units to sell
20.51K
Market value
$1.58M
12/19/2025
—Completed
Units to sell
3.20K
Market value
$240.4K
12/18/2025
—Completed
Units to sell
40.29K
Market value
$3.04M
12/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.45K
Market value
$111.2K
1/8/2026
Total
Units
68.59K
Value
$5.22M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/7/2026 | 1.35K | $104.8K | — | Completed |
1/6/2026 | 1.79K | $137.7K | — | Completed |
12/19/2025 | 20.51K | $1.58M | — | Completed |
12/18/2025 | 3.20K | $240.4K | — | Completed |
12/17/2025 | 40.29K | $3.04M | — | Completed |
| Planned — Approximate Date | ||||
1/8/2026 | 1.45K | $111.2K | NASDAQ | Planned |
| Total | 68.59K | $5.22M | ||